| Primary |
| Drug Use For Unknown Indication |
19.1% |
| Staphylococcal Infection |
12.3% |
| Product Used For Unknown Indication |
10.8% |
| Infection |
6.5% |
| Osteomyelitis |
6.5% |
| Pneumonia |
6.4% |
| Cellulitis |
5.8% |
| Endocarditis |
4.1% |
| Prophylaxis |
4.1% |
| Antibiotic Therapy |
3.9% |
| Antibiotic Prophylaxis |
3.2% |
| Hypertension |
3.2% |
| Arthritis Bacterial |
2.2% |
| Bacterial Infection |
2.2% |
| Clostridial Infection |
2.1% |
| Pneumonia Staphylococcal |
1.9% |
| Pain |
1.5% |
| Sepsis |
1.5% |
| Anti-infective Therapy |
1.3% |
| Bacteraemia |
1.3% |
|
| Drug Hypersensitivity |
12.8% |
| Renal Failure Acute |
10.5% |
| Red Man Syndrome |
9.8% |
| Rash |
9.5% |
| Thrombocytopenia |
7.8% |
| Renal Failure |
6.8% |
| Drug Ineffective |
4.7% |
| Urticaria |
4.1% |
| Anaphylactic Reaction |
3.4% |
| Linear Iga Disease |
3.4% |
| Nephropathy Toxic |
3.4% |
| Pruritus |
3.4% |
| Hypersensitivity |
3.0% |
| Toxic Epidermal Necrolysis |
3.0% |
| Systemic Candida |
2.7% |
| Tubulointerstitial Nephritis |
2.7% |
| Blood Creatinine Increased |
2.4% |
| Renal Impairment |
2.4% |
| Vomiting |
2.4% |
| Antibiotic Level Above Therapeutic |
2.0% |
|
| Secondary |
| Drug Use For Unknown Indication |
24.1% |
| Product Used For Unknown Indication |
20.9% |
| Pneumonia |
6.1% |
| Staphylococcal Infection |
5.6% |
| Infection |
4.5% |
| Prophylaxis |
4.4% |
| Hypertension |
4.1% |
| Sepsis |
3.6% |
| Pyrexia |
3.5% |
| Endocarditis |
3.1% |
| Pain |
2.4% |
| Antibiotic Therapy |
2.2% |
| Bacteraemia |
2.2% |
| Febrile Neutropenia |
2.2% |
| Drug Exposure During Pregnancy |
2.1% |
| Streptococcal Infection |
1.9% |
| Cellulitis |
1.8% |
| Corynebacterium Infection |
1.8% |
| Enterobacter Infection |
1.8% |
| Enterococcal Infection |
1.8% |
|
| Drug Hypersensitivity |
10.1% |
| Renal Failure Acute |
9.4% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
8.0% |
| Renal Failure |
6.9% |
| Renal Impairment |
5.8% |
| Thrombocytopenia |
5.8% |
| Toxic Epidermal Necrolysis |
5.4% |
| Toxic Skin Eruption |
5.4% |
| Sepsis |
5.1% |
| Drug Ineffective |
4.7% |
| Stevens-johnson Syndrome |
4.7% |
| Septic Shock |
4.0% |
| Skin Exfoliation |
4.0% |
| Pseudomembranous Colitis |
3.3% |
| Tubulointerstitial Nephritis |
3.3% |
| Vomiting |
3.3% |
| Neutropenia |
2.9% |
| Pyrexia |
2.9% |
| Drug Reaction With Eosinophilia And Systemic Symptoms |
2.5% |
| Pancytopenia |
2.5% |
|
| Concomitant |
| Drug Use For Unknown Indication |
37.1% |
| Product Used For Unknown Indication |
26.0% |
| Prophylaxis |
5.7% |
| Infection Prophylaxis |
3.5% |
| Pneumonia |
2.7% |
| Pain |
2.4% |
| Acute Myeloid Leukaemia |
2.3% |
| Infection |
2.2% |
| Hypertension |
2.1% |
| Sepsis |
2.0% |
| Bone Marrow Conditioning Regimen |
2.0% |
| Prophylaxis Against Graft Versus Host Disease |
1.9% |
| Acute Lymphocytic Leukaemia |
1.7% |
| Chronic Myeloid Leukaemia |
1.6% |
| Multiple Myeloma |
1.5% |
| Premedication |
1.2% |
| Pyrexia |
1.2% |
| Immunosuppression |
1.1% |
| Hiv Infection |
1.0% |
| Constipation |
1.0% |
|
| Vomiting |
10.8% |
| White Blood Cell Count Decreased |
9.4% |
| Pyrexia |
8.3% |
| Sepsis |
8.3% |
| Respiratory Failure |
7.6% |
| Thrombocytopenia |
7.3% |
| Renal Failure |
5.9% |
| Death |
4.5% |
| Pneumonia |
4.2% |
| Septic Shock |
3.8% |
| Rectal Haemorrhage |
3.5% |
| Renal Impairment |
3.5% |
| Pancytopenia |
3.1% |
| Staphylococcal Infection |
3.1% |
| Pain |
2.8% |
| Platelet Count Decreased |
2.8% |
| Rhabdomyolysis |
2.8% |
| Shock |
2.8% |
| Weight Decreased |
2.8% |
| Weight Increased |
2.8% |
|
| Interacting |
| Bronchopulmonary Aspergillosis |
13.8% |
| Localised Infection |
13.8% |
| Staphylococcal Infection |
13.8% |
| Prophylaxis |
10.3% |
| Depression |
6.9% |
| Mycosis Fungoides |
6.9% |
| Ovarian Abscess |
6.9% |
| Psoriatic Arthropathy |
6.9% |
| Restless Legs Syndrome |
6.9% |
| Sleep Disorder |
6.9% |
| Rheumatoid Arthritis |
3.4% |
| Wound Infection |
3.4% |
|
| Renal Failure Acute |
38.5% |
| Drug Interaction |
23.1% |
| Anxiety |
7.7% |
| Nephropathy Toxic |
7.7% |
| Proteus Infection |
7.7% |
| Tachycardia |
7.7% |
| Wound Infection |
7.7% |
|
